Under pressure over rising drug prices, pharmaceutical companies are pushing a new defense: They’re not raising prices to make money or to cover research costs, but rather to pay a cut to middlemen in the supply chain.
from WSJ.com: US Business https://on.wsj.com/2Sz3yfO
via IFTTT
No comments:
Post a Comment